CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 398,400 shares at $1.25 ($498,000)
- 4 Open-market buy Director bought 288,000 shares at $1.25 ($360,000)
- 4 Open-market buy President and CEO bought 48,000 shares at $1.25 ($60,000)
- 4 Open-market buy President and CEO bought 700 shares at $1.83 ($1,281)
- 4 Open-market buy President and CEO bought 100 shares at $1.83 ($183)
- 4 Open-market buy President and CEO bought 400 shares at $1.75 ($700)
- 4 Open-market buy President and CEO bought 1,700 shares at $1.76 ($2,989)
- 4 Open-market buy Chief Financial Officer bought 4,819 shares at $2.08 ($9,999)
- 4 Open-market buy President and CEO bought 24,096 shares at $2.08 ($49,999)
- 4 Open-market buy Director bought 72,289 shares at $2.08 ($150,000)
- 4 Open-market buy Director bought 72,289 shares at $2.08 ($150,000)
- 4 Open-market buy President and CEO bought 100 shares at $2.21 ($221)
- 4 Open-market buy President and CEO bought 2,300 shares at an average $2.02 ($4,651)
- 4 Open-market buy President and CEO bought 400 shares at an average $2.57 ($1,028)
- 4 Open-market buy Director bought 13,123 shares at $1.91 ($24,999)
Page 3 of 23 · 442 filings